SLXP up +1.95% percent Today $SLXP High is at 95.4
Post# of 37
Posted On: 11/10/2014 1:01:43 PM
SLXP up +1.95% percent Today $SLXP High is at 95.46 and the Low 90.00 with current volume of 2,105,868.
Recent News posted below.
Salix Pharmaceuticals SLXP other info.
http://investorshangout.com/Salix-Pharmaceuti...LXP-55453/
SLXP Salix Pharmaceuticals Recent Headline News
Wolf Popper LLP Announces Investigation on Behalf of Investors in Salix Pharmaceuticals Ltd.
PR Newswire - 52 mins ago
Wolf Popper LLP is investigating potential claims on behalf of investors in Salix Pharmaceuticals Ltd. ("Salix"
common stock (NASDAQ: SLXP) during the period May 10, 2013 through November 6, 2014, concerning possible violations of federal securities laws. Such investors are advised to contact Fei-Lu Qian at 877.370.7703 or fqian@wolfpopper.com.
SLXP: 94.47 (+3.00)
Morgan & Morgan Announces That a Class Action Lawsuit Has Been Filed Against Salix Pharmaceuticals Ltd. -- SLXP
GlobeNewswire - 1 hr 20 mins ago
Morgan & Morgan announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Salix Pharmaceuticals Ltd. ("Salix" or the "Company" (Nasdaq:SLXP) securities between November 8, 2013 and November 6, 2014, inclusive (the "Class Period" .
SLXP: 94.47 (+3.00)
Trade-Ideas: Salix Pharmaceuticals (SLXP) Is Today's "Dead Cat Bounce" Stock
at The Street - Mon Nov 10, 8:51AM CST
Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a "dead cat bounce" (down big yesterday but up big today) candidate
SLXP: 94.47 (+3.00)
Salix Pharmaceuticals (SLXP) Downgraded From Buy to Hold
at The Street - Mon Nov 10, 8:35AM CST
Salix Pharmaceuticals SLXP has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C+. TheStreet Ratings Team has this to say about their recommendation:
SLXP: 94.47 (+3.00)
Deadline in Lawsuit for Investors in Salix Pharmaceuticals, Ltd. (SLXP) Shares Announced by Shareholders Foundation
GlobeNewswire - Mon Nov 10, 8:30AM CST
The Shareholders Foundation, Inc. announces that a lawsuit was filed on behalf of certain purchasers of shares of Salix Pharmaceuticals, Ltd. (SLXP) over alleged Federal Securities Laws Violations by Salix Pharmaceuticals, Ltd.
SLXP: 94.47 (+3.00)
Downgrade Alert for Salix Pharmaceuticals (SLXP)
Comtex SmarTrend(R) - Mon Nov 10, 8:04AM CST
Salix Pharmaceuticals (NASDAQ:SLXP) was downgraded from Buy to Neutral at Mizuho today. The stock closed yesterday at $91.47 on volume of 25.8 million shares, above average daily volume of 2.0 million. In the past 52 weeks, shares of Salix Pharmaceuticals have traded between a low of $82.52 and a high of $172.98 and closed yesterday at $91.47, which is 11% above that low price. The 200-day and 50-day moving averages have moved 0.63% higher and 1.83% lower over the past week, respectively.
SLXP: 94.47 (+3.00)
'Fast Money' Recap: When Is the Best Time to Buy Twitter Stock?
at The Street - Sat Nov 08, 4:00AM CST
The trading panel discussed whether it would help or hurt Twitter if its CEO steps down and whether Coca-Cola has any fizz left in it.
KO: 42.38 (+0.06), YHOO: 49.19 (+0.64), MNST: 107.00 (-1.39), ANF: 28.51 (-0.99), SLXP: 94.47 (+3.00), FFIV: 126.09 (-0.57), AKS: 6.55 (-0.07), TWTR: 40.03 (-0.28), GDX: 17.77 (-0.87), FXF: 100.98 (-0.12)
Labaton Sucharow LLP Has Filed a Class Action Lawsuit on Behalf of Investors in Salix Pharmaceuticals, Ltd. (SLXP)
GlobeNewswire - Fri Nov 07, 10:12PM CST
Labaton Sucharow LLP ("Labaton Sucharow" filed a securities class action lawsuit on behalf of Woburn Retirement System in the U.S. District Court for the Southern District of New York. The lawsuit was filed on behalf of all persons or entities who, between November 8, 2013 and November 6, 2014, inclusive (the "Class Period" , purchased or otherwise acquired the securities of Salix Pharmaceuticals, Ltd. ("Salix" or the "Company" (Nasdaq:SLXP).
SLXP: 94.47 (+3.00)
SALIX INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Salix Pharmaceuticals Ltd. Following Disclosure of Disappointing Third Quarter Results and Resignation of CFO
Business Wire - Fri Nov 07, 9:00PM CST
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF" , announces that KSF has commenced an investigation into Salix Pharmaceuticals Ltd. (Nasdaq: SLXP).
SLXP: 94.47 (+3.00)
Harwood Feffer LLP Announces Investigation of Salix Pharmaceuticals Ltd.
PR Newswire - Fri Nov 07, 7:10PM CST
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Salix Pharmaceuticals Ltd. ("Salix" or the "Company" (NASDAQ: SLXP), concerning whether the board has breached its fiduciary duties to shareholders.
SLXP: 94.47 (+3.00)
Health Sell-Offs Drag On IBD 50
at Investor's Business Daily - Fri Nov 07, 6:31PM CST
The IBD 50 was lower last week as several stocks in health care sold off, dragging down the index's performance. After two weeks of feverish gains, the IBD 50 components cooled off the first week of November. The index was down 1.4% last week,...
BCC: 36.44 (-0.99), LCI: 51.20 (+1.03), AKRX: 35.21 (-1.38), AFSI: 50.55 (+0.66), EXPE: 85.99 (+0.88), FFIV: 126.09 (-0.57), SLXP: 94.47 (+3.00), MPWR: 44.63 (-0.06), TMH: 53.61 (-0.53), ATHM: 44.02 (+0.39)
Nasdaq stocks posting largest percentage decreases
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
TNGO: 12.25 (+0.01), PRSC: 38.20 (-0.28), FNGN: 30.52 (-0.87), LACO: 6.93 (+0.02), MSON: 11.32 (-0.48), SLXP: 94.47 (+3.00), FNHC: 26.33 (+0.19), MDRX: 11.38 (-0.16), PCMI: 8.41 (+0.96), UBNT: 29.22 (+0.44), PFMT: 6.61 (-0.43), ICPT: 176.58 (+3.99), ANDE: 54.06 (-0.73), ACTA: 16.61 (+0.09)
Federman & Sherwood Investigates Salix Pharmaceuticals, Ltd. for Possible Violations of Federal Securities Laws
Business Wire - Fri Nov 07, 4:23PM CST
The law firm of Federman & Sherwood has launched an investigation into Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) ("Salix" for possible violations of federal securities laws.
SLXP: 94.49 (+3.02)
Market News: Sears, Salix Pharmaceuticals, Walt Disney
at The Street - Fri Nov 07, 3:38PM CST
The Department of Labor reported that American companies added 214,000 jobs and the unemployment rate declined to 5.8%The stock markets in the United States fluctuated and eventually ended the trading...
SLXP: 94.52 (+3.05), DIS: 89.15 (-0.85), SHLD: 40.53 (-2.28)
Stock Movers: Why These 4 Medical Stocks Dived Today
at Investor's Business Daily - Fri Nov 07, 3:36PM CST
Raised eyebrows can lead to declining stock prices. Stocks On The Move down today include Salix Pharmaceuticals (SLXP), embroiled in drama as questions of accuracy and honesty cloud the drugmaker's weak Q3 results. Are its inventories accurate, and...
AGN: 195.69 (-0.31), VRX: 127.51 (+1.40), DVA: 74.51 (+0.02), GILD: 107.07 (+0.62), SLXP: 94.52 (+3.05), ICPT: 176.58 (+3.99), HUM: 132.46 (+1.88)
Look for Shares of Salix Pharmaceuticals to Potentially Rebound after Yesterday's 33.98% Sell Off
Comtex SmarTrend(R) - Fri Nov 07, 3:35PM CST
Salix Pharmaceuticals (NASDAQ:SLXP) traded in a range yesterday that spanned from a low of $86.00 to a high of $96.00. Yesterday, the shares fell 34.0%, which took the trading range below the 3-day low of $134.40 on volume of 25.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SLXP: 94.52 (+3.05)
Humana and Salix are big market movers
AP - Fri Nov 07, 3:34PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
WFM: 47.57 (+0.76), TSLA: 241.38 (+1.18), FSLR: 52.10 (+1.81), RIG: 29.62 (-0.09), WWWW: 15.53 (+0.13), GNRC: 40.66 (-0.20), SLXP: 94.52 (+3.05), BRKR: 17.93 (+0.02), KATE: 30.14 (-0.23), GNW: 8.33 (-0.08), SHLD: 40.53 (-2.28), ANR: 2.64 (-0.27), MCO: 99.28 (+0.33), HUM: 132.46 (+1.88)
Dow, S&P 500 Flirt With Record, But Finish Just Off
at Investor's Business Daily - Fri Nov 07, 3:28PM CST
Stocks finished narrowly mixed Friday after the Dow Jones industrial average and the S&P 500 hit record intraday highs, then drifted off in the final hours of trading. The Nasdaq finished down 0.2%, the Dow climbed 0.1% and the S&P 500 was...
MNST: 107.00 (-1.39), SLXP: 94.49 (+3.02), DIS: 89.15 (-0.85)
Stock Market Today: Dow Scores Third Straight Record Close on Jobs Data
at The Street - Fri Nov 07, 3:22PM CST
The Dow Jones Industrial Average posts a small gain in the final minutes to closing bell, just enough to cement the index's third consecutive record close.
MNST: 107.00 (-1.39), FSLR: 52.10 (+1.81), SLXP: 94.49 (+3.02), AKS: 6.55 (-0.07), SHLD: 40.53 (-2.28), VSAT: 62.69 (-2.70)
Why Salix Pharmaceuticals Ltd. Stock Was Throttled
Sean Williams, The Motley Fool - Motley Fool - Fri Nov 07, 2:45PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Salix Pharmaceuticals , a biopharmaceutical company...
SLXP: 94.49 (+3.02)
Recent News posted below.
Salix Pharmaceuticals SLXP other info.
http://investorshangout.com/Salix-Pharmaceuti...LXP-55453/
SLXP Salix Pharmaceuticals Recent Headline News
Wolf Popper LLP Announces Investigation on Behalf of Investors in Salix Pharmaceuticals Ltd.
PR Newswire - 52 mins ago
Wolf Popper LLP is investigating potential claims on behalf of investors in Salix Pharmaceuticals Ltd. ("Salix"
common stock (NASDAQ: SLXP) during the period May 10, 2013 through November 6, 2014, concerning possible violations of federal securities laws. Such investors are advised to contact Fei-Lu Qian at 877.370.7703 or fqian@wolfpopper.com. SLXP: 94.47 (+3.00)
Morgan & Morgan Announces That a Class Action Lawsuit Has Been Filed Against Salix Pharmaceuticals Ltd. -- SLXP
GlobeNewswire - 1 hr 20 mins ago
Morgan & Morgan announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Salix Pharmaceuticals Ltd. ("Salix" or the "Company"
(Nasdaq:SLXP) securities between November 8, 2013 and November 6, 2014, inclusive (the "Class Period" . SLXP: 94.47 (+3.00)
Trade-Ideas: Salix Pharmaceuticals (SLXP) Is Today's "Dead Cat Bounce" Stock
at The Street - Mon Nov 10, 8:51AM CST
Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a "dead cat bounce" (down big yesterday but up big today) candidate
SLXP: 94.47 (+3.00)
Salix Pharmaceuticals (SLXP) Downgraded From Buy to Hold
at The Street - Mon Nov 10, 8:35AM CST
Salix Pharmaceuticals SLXP has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C+. TheStreet Ratings Team has this to say about their recommendation:
SLXP: 94.47 (+3.00)
Deadline in Lawsuit for Investors in Salix Pharmaceuticals, Ltd. (SLXP) Shares Announced by Shareholders Foundation
GlobeNewswire - Mon Nov 10, 8:30AM CST
The Shareholders Foundation, Inc. announces that a lawsuit was filed on behalf of certain purchasers of shares of Salix Pharmaceuticals, Ltd. (SLXP) over alleged Federal Securities Laws Violations by Salix Pharmaceuticals, Ltd.
SLXP: 94.47 (+3.00)
Downgrade Alert for Salix Pharmaceuticals (SLXP)
Comtex SmarTrend(R) - Mon Nov 10, 8:04AM CST
Salix Pharmaceuticals (NASDAQ:SLXP) was downgraded from Buy to Neutral at Mizuho today. The stock closed yesterday at $91.47 on volume of 25.8 million shares, above average daily volume of 2.0 million. In the past 52 weeks, shares of Salix Pharmaceuticals have traded between a low of $82.52 and a high of $172.98 and closed yesterday at $91.47, which is 11% above that low price. The 200-day and 50-day moving averages have moved 0.63% higher and 1.83% lower over the past week, respectively.
SLXP: 94.47 (+3.00)
'Fast Money' Recap: When Is the Best Time to Buy Twitter Stock?
at The Street - Sat Nov 08, 4:00AM CST
The trading panel discussed whether it would help or hurt Twitter if its CEO steps down and whether Coca-Cola has any fizz left in it.
KO: 42.38 (+0.06), YHOO: 49.19 (+0.64), MNST: 107.00 (-1.39), ANF: 28.51 (-0.99), SLXP: 94.47 (+3.00), FFIV: 126.09 (-0.57), AKS: 6.55 (-0.07), TWTR: 40.03 (-0.28), GDX: 17.77 (-0.87), FXF: 100.98 (-0.12)
Labaton Sucharow LLP Has Filed a Class Action Lawsuit on Behalf of Investors in Salix Pharmaceuticals, Ltd. (SLXP)
GlobeNewswire - Fri Nov 07, 10:12PM CST
Labaton Sucharow LLP ("Labaton Sucharow"
filed a securities class action lawsuit on behalf of Woburn Retirement System in the U.S. District Court for the Southern District of New York. The lawsuit was filed on behalf of all persons or entities who, between November 8, 2013 and November 6, 2014, inclusive (the "Class Period" , purchased or otherwise acquired the securities of Salix Pharmaceuticals, Ltd. ("Salix" or the "Company" (Nasdaq:SLXP). SLXP: 94.47 (+3.00)
SALIX INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Salix Pharmaceuticals Ltd. Following Disclosure of Disappointing Third Quarter Results and Resignation of CFO
Business Wire - Fri Nov 07, 9:00PM CST
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"
, announces that KSF has commenced an investigation into Salix Pharmaceuticals Ltd. (Nasdaq: SLXP). SLXP: 94.47 (+3.00)
Harwood Feffer LLP Announces Investigation of Salix Pharmaceuticals Ltd.
PR Newswire - Fri Nov 07, 7:10PM CST
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Salix Pharmaceuticals Ltd. ("Salix" or the "Company"
(NASDAQ: SLXP), concerning whether the board has breached its fiduciary duties to shareholders. SLXP: 94.47 (+3.00)
Health Sell-Offs Drag On IBD 50
at Investor's Business Daily - Fri Nov 07, 6:31PM CST
The IBD 50 was lower last week as several stocks in health care sold off, dragging down the index's performance. After two weeks of feverish gains, the IBD 50 components cooled off the first week of November. The index was down 1.4% last week,...
BCC: 36.44 (-0.99), LCI: 51.20 (+1.03), AKRX: 35.21 (-1.38), AFSI: 50.55 (+0.66), EXPE: 85.99 (+0.88), FFIV: 126.09 (-0.57), SLXP: 94.47 (+3.00), MPWR: 44.63 (-0.06), TMH: 53.61 (-0.53), ATHM: 44.02 (+0.39)
Nasdaq stocks posting largest percentage decreases
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
TNGO: 12.25 (+0.01), PRSC: 38.20 (-0.28), FNGN: 30.52 (-0.87), LACO: 6.93 (+0.02), MSON: 11.32 (-0.48), SLXP: 94.47 (+3.00), FNHC: 26.33 (+0.19), MDRX: 11.38 (-0.16), PCMI: 8.41 (+0.96), UBNT: 29.22 (+0.44), PFMT: 6.61 (-0.43), ICPT: 176.58 (+3.99), ANDE: 54.06 (-0.73), ACTA: 16.61 (+0.09)
Federman & Sherwood Investigates Salix Pharmaceuticals, Ltd. for Possible Violations of Federal Securities Laws
Business Wire - Fri Nov 07, 4:23PM CST
The law firm of Federman & Sherwood has launched an investigation into Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) ("Salix"
for possible violations of federal securities laws. SLXP: 94.49 (+3.02)
Market News: Sears, Salix Pharmaceuticals, Walt Disney
at The Street - Fri Nov 07, 3:38PM CST
The Department of Labor reported that American companies added 214,000 jobs and the unemployment rate declined to 5.8%The stock markets in the United States fluctuated and eventually ended the trading...
SLXP: 94.52 (+3.05), DIS: 89.15 (-0.85), SHLD: 40.53 (-2.28)
Stock Movers: Why These 4 Medical Stocks Dived Today
at Investor's Business Daily - Fri Nov 07, 3:36PM CST
Raised eyebrows can lead to declining stock prices. Stocks On The Move down today include Salix Pharmaceuticals (SLXP), embroiled in drama as questions of accuracy and honesty cloud the drugmaker's weak Q3 results. Are its inventories accurate, and...
AGN: 195.69 (-0.31), VRX: 127.51 (+1.40), DVA: 74.51 (+0.02), GILD: 107.07 (+0.62), SLXP: 94.52 (+3.05), ICPT: 176.58 (+3.99), HUM: 132.46 (+1.88)
Look for Shares of Salix Pharmaceuticals to Potentially Rebound after Yesterday's 33.98% Sell Off
Comtex SmarTrend(R) - Fri Nov 07, 3:35PM CST
Salix Pharmaceuticals (NASDAQ:SLXP) traded in a range yesterday that spanned from a low of $86.00 to a high of $96.00. Yesterday, the shares fell 34.0%, which took the trading range below the 3-day low of $134.40 on volume of 25.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SLXP: 94.52 (+3.05)
Humana and Salix are big market movers
AP - Fri Nov 07, 3:34PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
WFM: 47.57 (+0.76), TSLA: 241.38 (+1.18), FSLR: 52.10 (+1.81), RIG: 29.62 (-0.09), WWWW: 15.53 (+0.13), GNRC: 40.66 (-0.20), SLXP: 94.52 (+3.05), BRKR: 17.93 (+0.02), KATE: 30.14 (-0.23), GNW: 8.33 (-0.08), SHLD: 40.53 (-2.28), ANR: 2.64 (-0.27), MCO: 99.28 (+0.33), HUM: 132.46 (+1.88)
Dow, S&P 500 Flirt With Record, But Finish Just Off
at Investor's Business Daily - Fri Nov 07, 3:28PM CST
Stocks finished narrowly mixed Friday after the Dow Jones industrial average and the S&P 500 hit record intraday highs, then drifted off in the final hours of trading. The Nasdaq finished down 0.2%, the Dow climbed 0.1% and the S&P 500 was...
MNST: 107.00 (-1.39), SLXP: 94.49 (+3.02), DIS: 89.15 (-0.85)
Stock Market Today: Dow Scores Third Straight Record Close on Jobs Data
at The Street - Fri Nov 07, 3:22PM CST
The Dow Jones Industrial Average posts a small gain in the final minutes to closing bell, just enough to cement the index's third consecutive record close.
MNST: 107.00 (-1.39), FSLR: 52.10 (+1.81), SLXP: 94.49 (+3.02), AKS: 6.55 (-0.07), SHLD: 40.53 (-2.28), VSAT: 62.69 (-2.70)
Why Salix Pharmaceuticals Ltd. Stock Was Throttled
Sean Williams, The Motley Fool - Motley Fool - Fri Nov 07, 2:45PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Salix Pharmaceuticals , a biopharmaceutical company...
SLXP: 94.49 (+3.02)
(0)
(0)Salix Pharmaceuticals Ltd. (SLXP) Stock Research Links
Scroll down for more posts ▼